Discovery of clinical and demographic determinants of symptom burden in primary brain tumor patients using network analysis and unsupervised clustering.
Bergsneider BH, Vera E, Gal O, Christ A, King AL, Acquaye A, Choi A, Leeper HE, Mendoza T, Boris L, Burton E, Lollo N, Panzer M, Penas-Prado M, Pillai T, Polskin L, Wu J, Gilbert MR, Armstrong TS, Celiku O.
Bergsneider BH, et al. Among authors: gal o.
Neurooncol Adv. 2022 Dec 26;5(1):vdac188. doi: 10.1093/noajnl/vdac188. eCollection 2023 Jan-Dec.
Neurooncol Adv. 2022.
PMID: 36820236
Free PMC article.